Objectives – Sildenafil citrate is widely used for erectile dysfunction. The present study examined the short-term effects of sildenafil administration in individuals with cerebrovascular risk factors, including patients with a history of stroke. Materials and Methods – Twenty-five consecutive male patients with erectile dysfunction and vascular risk factors were included in the study. A perfusion brain SPECT study was performed at baseline and 1 h after the oral administration of sildenafil. Results – Associations between any of the risk factors and the perfusion scores were not detected, with the exception of stroke. Stroke patients showed significantly more areas with diminished perfusion after sildenafil administration compare...
The pharmaceutical preparation sildenafil citrate (Viagra) is being widely prescribed as a treatment...
is a potent vasodilating agent to treat male erectile dysfunction. Among its adverse effects, hemorr...
Background: Since its approval by the US Food and Drug Administration in March 1998, sildenafil citr...
INTRODUCTION:Erectile dysfunction (ED) is one of the most encountered male health problem and silden...
INTRODUCTION:Erectile dysfunction (ED) is one of the most encountered male health problem and silden...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...
Background: Erectile and cardiovascular dysfunctions in diabetes are important signs resulting proba...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
Introduction: Sildenafil is a phosphodiesterase 5 enzyme inhibitor used in the treatment of erectile...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
Sildenafil citrate (Viagra; Pfizer Inc, New York, NY) relaxes vascular smooth muscle, resulting in m...
Sildenafil citrate (Viagra (R); Pfeizer US Pharmaceutical Group, New York, NY, USA) is a potent vaso...
Sildenafil citrate (Viagra (R); Pfeizer US Pharmaceutical Group, New York, NY, USA) is a potent vaso...
The pharmaceutical preparation sildenafil citrate (Viagra) is being widely prescribed as a treatment...
is a potent vasodilating agent to treat male erectile dysfunction. Among its adverse effects, hemorr...
Background: Since its approval by the US Food and Drug Administration in March 1998, sildenafil citr...
INTRODUCTION:Erectile dysfunction (ED) is one of the most encountered male health problem and silden...
INTRODUCTION:Erectile dysfunction (ED) is one of the most encountered male health problem and silden...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...
Background: Erectile and cardiovascular dysfunctions in diabetes are important signs resulting proba...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
Introduction: Sildenafil is a phosphodiesterase 5 enzyme inhibitor used in the treatment of erectile...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
The authors performed a double-blind, placebo-controlled study in 28 patients to evaluate the effect...
Sildenafil citrate (Viagra; Pfizer Inc, New York, NY) relaxes vascular smooth muscle, resulting in m...
Sildenafil citrate (Viagra (R); Pfeizer US Pharmaceutical Group, New York, NY, USA) is a potent vaso...
Sildenafil citrate (Viagra (R); Pfeizer US Pharmaceutical Group, New York, NY, USA) is a potent vaso...
The pharmaceutical preparation sildenafil citrate (Viagra) is being widely prescribed as a treatment...
is a potent vasodilating agent to treat male erectile dysfunction. Among its adverse effects, hemorr...
Background: Since its approval by the US Food and Drug Administration in March 1998, sildenafil citr...